Is it time to fund non-invasive prenatal testing for all women?
In less than a decade, prenatal screening has been transformed.
The introduction of non-invasive prenatal testing, also known as cell-free DNA testing, means women can now undergo more accurate, non-invasive screening for fetal abnormalities earlier in their pregnancy.
But it’s an option that remains out of reach for many.
A logical test to fund
Non-invasive prenatal testing (NIPT) was first introduced commercially in Australia in 2012, but remains unfunded by either Medicare or private health insurers. Women must pay $400 or more